Christopher Mills - Jul 1, 2023 Form 3 Insider Report for Renalytix plc (RNLX)

Role
Director, 10%+ Owner
Signature
/s/ Katie Kazem, Attorney-in-Fact
Stock symbol
RNLX
Transactions as of
Jul 1, 2023
Transactions value $
$0
Form type
3
Date filed
7/3/2023, 04:23 PM
Next filing
Nov 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RNLX Ordinary Shares 6.46M Jul 1, 2023 By North Atlantic Smaller Companies Investment Trust plc F1, F2
holding RNLX Ordinary Shares 2.81M Jul 1, 2023 By Oryx International Growth Fund Limited F1, F3
holding RNLX Ordinary Shares 801K Jul 1, 2023 By Harwood Capital LLP F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each representing two Ordinary Shares.
F2 The securities are directly held by North Atlantic Smaller Companies Investment Trust plc ("North Atlantic"). The Reporting Person is the Partner and Chief Investment Officer of Harwood Capital LLP ("Harwood"). Harwood is the Investment Manager to North Atlantic. The Reporting Person disclaims beneficial ownership of the securities held by North Atlantic except to the extent of his pecuniary interest therein.
F3 The securities are directly held by Oryx International Growth Fund Limited ("Oryx"). The Reporting Person is the Partner and Chief Investment Officer of Harwood. Harwood is the investment adviser to Oryx. The Reporting Person disclaims beneficial ownership of the securities held by Oryx except to the extent of his pecuniary interest therein.
F4 The securities are directly held by Harwood. The Reporting Person is the Partner and Chief Investment Officer of Harwood. The Reporting Person disclaims beneficial ownership of the securities held by Harwood except to the extent of his pecuniary interest therein.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney